HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study dataset

A cohort study was conducted from 2018-2020 among 311 adolescents living with perinatally acquired HIV (APHI) receiving antiretroviral therapy (ART) in one of the selected health facilities within the “Resistance Evolution among Adolescents in Yaoundé and its surroundings” (READY-study) in the Centre region of Cameroon. Participants were recruited following consecutive and exhaustive sampling. Follow-up was performed at enrollment (Phase 1), at 6 months (Phase 2), and 12 months (Phase 3).